Jane Street Group, LLC Bausch Health Companies Inc. Transaction History

Jane Street Group, LLC

$384 Billion
Q1 2025

A detailed history of Jane Street Group, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 97,146 shares of BHC stock, worth $680,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,146

Previous 77,400 25.51%

Holding current value

$680,022

Previous $500,000 25.6%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$6.16 - $7.94 $838,394 - $1.08 Million	-136,103 Reduced 58.35%	97,146 $628,000
Q4 2024 Feb 14, 2025	SELL	$7.34 - $9.78 $97,321 - $129,673	-13,259 Reduced 5.38%	233,249 $1.88 Million
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $550,736 - $871,471	105,505 Added 74.82%	246,508 $2.01 Million
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $1.39 Million - $2.37 Million	-227,451 Reduced 61.73%	141,003 $982,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $1.44 Million - $1.97 Million	-185,609 Reduced 33.5%	368,454 $3.91 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $876,443 - $1.1 Million	-134,218 Reduced 19.5%	554,063 $4.44 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $439,983 - $555,557	57,215 Added 9.07%	688,281 $5.66 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $82,419 - $126,799	14,409 Added 2.34%	631,066 $5.05 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $7.51 Million - $11.8 Million	-1,195,138 Reduced 65.96%	616,657 $4.99 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $4.2 Million - $5.47 Million	689,203 Added 61.39%	1,811,795 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $4.3 Million - $8.65 Million	939,629 Added 513.56%	1,122,592 $7.74 Million
Q2 2022 Aug 16, 2022	SELL	$7.06 - $23.63 $18.3 Million - $61.4 Million	-2,597,107 Reduced 93.42%	182,963 $1.53 Million
Q1 2022 May 17, 2022	BUY	$21.6 - $27.79 $44.1 Million - $56.8 Million	2,043,877 Added 277.63%	2,780,070 $63.5 Million
Q4 2021 Feb 15, 2022	BUY	$23.0 - $29.01 $8.74 Million - $11 Million	379,914 Added 106.63%	736,193 $20.3 Million
Q3 2021 Nov 16, 2021	SELL	$25.04 - $30.06 $7.87 Million - $9.45 Million	-314,466 Reduced 46.88%	356,279 $9.92 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $12.9 Million - $15.4 Million	471,314 Added 236.33%	670,745 $19.7 Million
Q1 2021 May 18, 2021	SELL	$21.37 - $34.38 $6.71 Million - $10.8 Million	-313,862 Reduced 61.15%	199,431 $6.33 Million
Q4 2020 Feb 17, 2021	SELL	$15.31 - $21.12 $1.35 Million - $1.86 Million	-88,080 Reduced 14.65%	513,293 $10.7 Million
Q3 2020 Nov 17, 2020	SELL	$14.88 - $20.13 $380,749 - $515,086	-25,588 Reduced 4.08%	601,373 $9.35 Million
Q2 2020 Aug 17, 2020	BUY	$13.31 - $20.51 $7.58 Million - $11.7 Million	569,185 Added 985.16%	626,961 $11.5 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $2.75 Million - $6.41 Million	-212,047 Reduced 78.59%	57,776 $896,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $4.07 Million - $6.87 Million	215,351 Added 395.34%	269,823 $8.07 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $2.31 Million - $2.84 Million	-110,638 Reduced 67.01%	54,472 $1.19 Million
Q2 2019 Aug 15, 2019	SELL	$20.52 - $26.45 $1.49 Million - $1.92 Million	-72,747 Reduced 30.58%	165,110 $4.17 Million
Q1 2019 May 16, 2019	BUY	$20.23 - $26.29 $1.52 Million - $1.97 Million	75,042 Added 46.09%	237,857 $5.88 Million
Q4 2018 Feb 15, 2019	SELL	$17.64 - $28.32 $18,486 - $29,679	-1,048 Reduced 0.64%	162,815 $3.01 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $3.38 Million - $4.21 Million	163,863 New	163,863 $4.21 Million

Others Institutions Holding BHC

# of Institutions

263

Shares Held

243M

Call Options Held

3.72M

Put Options Held

11.3M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.53B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Bausch Health Companies Inc. Transaction History